Prof. Noopur S. Raje | 2017 ASCO Annual Meeting | Impact of denosumab (DMB) compared with zoledronic acid (ZA) on renal function in the treatment of myeloma bone disease
Jun 6, 2017
2017 ASCO Annual Meeting - 2-6 June, Chicago
Download this article:
You can now download this article in Adobe PDF® format.
Download as PDF